Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J Scolding

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Annals of Internal Medicine|March 1, 1988
Heparin and deep venous thrombosisP A Routledge, N J Scolding
Practical Neurology|July 20, 2007
Sarcoidosis of the nervous systemF G Joseph, N J Scolding
Journal of Neuroimmunology|June 12, 2003
Immune-modifying agents do not impair the survival, migration or proliferation of oligodendrocyte progenitors (CG-4) in vitroC A Halfpenny, N J Scolding
Lancet (London, England)|July 13, 2004
Adult stem cells--reprogramming neurological repair?C M Rice, N J Scolding
Immunology|January 1, 1991
Oligodendrocyte-macrophage interactions in vitro triggered by specific antibodiesN J Scolding, D A Compston
Neuropathology and Applied Neurobiology|June 13, 2002
The neuropathology and pathogenesis of systemic lupus erythematosusN J Scolding, F G Joseph
Bailliere'S Clinical Neurology|April 2, 1999
Remyelination in demyelinating diseaseN J Scolding, R J Franklin
Neuroscience Letters|January 2, 1995
Growth factors fail to protect rat oligodendrocytes against humoral injury in vitroN J Scolding, D A Compston
Journal of Neuroimmunology|March 4, 2000
Oligodendroglia are protected from antibody-mediated complement injury by normal immunoglobulins ("IVIg")M Stangel, A Compston, N J Scolding
Journal of Neuroimmunology|May 25, 1999
Polyclonal immunoglobulins for intravenous use do not influence the behaviour of cultured oligodendrocytesM Stangel, A Compston, N J Scolding
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Annals of Internal Medicine|March 1, 1988
Heparin and deep venous thrombosisP A Routledge, N J Scolding
Practical Neurology|July 20, 2007
Sarcoidosis of the nervous systemF G Joseph, N J Scolding
Journal of Neuroimmunology|June 12, 2003
Immune-modifying agents do not impair the survival, migration or proliferation of oligodendrocyte progenitors (CG-4) in vitroC A Halfpenny, N J Scolding
Lancet (London, England)|July 13, 2004
Adult stem cells--reprogramming neurological repair?C M Rice, N J Scolding
Immunology|January 1, 1991
Oligodendrocyte-macrophage interactions in vitro triggered by specific antibodiesN J Scolding, D A Compston
Neuropathology and Applied Neurobiology|June 13, 2002
The neuropathology and pathogenesis of systemic lupus erythematosusN J Scolding, F G Joseph
Bailliere'S Clinical Neurology|April 2, 1999
Remyelination in demyelinating diseaseN J Scolding, R J Franklin
Neuroscience Letters|January 2, 1995
Growth factors fail to protect rat oligodendrocytes against humoral injury in vitroN J Scolding, D A Compston
Journal of Neuroimmunology|March 4, 2000
Oligodendroglia are protected from antibody-mediated complement injury by normal immunoglobulins ("IVIg")M Stangel, A Compston, N J Scolding
Journal of Neuroimmunology|May 25, 1999
Polyclonal immunoglobulins for intravenous use do not influence the behaviour of cultured oligodendrocytesM Stangel, A Compston, N J Scolding
Pageof 8